Friday, November 6, 2020
- 9:00AM-11:00AM
-
Abstract Number: 0354
How Do TNF-alpha-Inhibitors in Medical History Affect Patient Reported Outcomes and Retention in Ankylosing Spondylitis Patients Treated with Secukinumab in Real World? – German Observational Study
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster I- 9:00AM-11:00AM
-
Abstract Number: 0149
How Stable Are Medication Necessity Beliefs and Safety Concerns in the First Year of RA?
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA- 9:00AM-11:00AM
-
Abstract Number: 0002
Hydroxychloroquine and Chloroquine and Hospitalizations for Viral Infection in the Pre-COVID-19 Era
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease- 9:00AM-11:00AM
-
Abstract Number: 0023
Hypophosphatasia May Be Misdiagnosed as Fibromyalgia: A Single Center Experience
Fibromyalgia & Other Clinical Pain Syndromes Poster- 9:00AM-11:00AM
-
Abstract Number: 0039
Identification of a Regulatory Pathway Governing Expression of TRAF1 via a JIA-associated Non-coding Variant
Genetics, Genomics & Proteomics Poster- 9:00AM-11:00AM
-
Abstract Number: 0069
Identification of CD13 as a Potential Cause for SARS-CoV-2-triggered Hyperinflammation and Thrombosis
Innate Immunity Poster- 9:00AM-11:00AM
-
Abstract Number: 0179
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning
RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity- 9:00AM-11:00AM
-
Abstract Number: 0175
Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing
Pediatric Rheumatology – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 0371
Identifying Inadequate Response Among Ankylosing Spondylitis Patients Prescribed Biologics in a Real-world Commercially Insured Adult Population in the United States
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster I- 9:00AM-11:00AM
-
Abstract Number: 0162
Identifying Sleep Problems in Systemic Juvenile Idiopathic Arthritis (SJIA) Patients with Patient-reported Outcomes (PRO) Questionnaires
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA- 9:00AM-11:00AM
-
Abstract Number: 0416
IgG4-related Retroperitoneal Fibrosis. Retrospective Cohort
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I- 9:00AM-11:00AM
-
Abstract Number: 0126
Immunophenotyping of Peripheral Blood Highlights an Association of Dysregulated Lymphocytes with Patients with Glucocorticoid-induced Osteonecrosis
Osteoporosis & Metabolic Bone Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 0168
Impact of Adalimumab (Humira) Therapy on Ocular Inflammation, Selected Health Care Resource Utilization, and Patient-Reported Outcomes in Patients with Active Non-infectious Intermediate, Posterior, or Panuveitis in Routine Clinical Practice
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA